Clinical Trial Update: A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and tolerability of single doses of AZD4076 in healthy male subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• AZD4076 (AZD4076)

Snippet

Sponsor: AstraZeneca | Conditions: Non-alcoholic Steatohepatitis (NASH) | Phase 1 | Status: COMPLETED